Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2021 | 03-2021 | 02-2021 | 11-2020 | 08-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,052 | N/A | 10,706 | 7,389 | 2,142 |
| Marketable Securities | N/A | N/A | 512 | N/A | N/A |
| Other current assets | 73 | 0 | 0 | 0 | 0 |
| TOTAL | $10,300 | $N/A | $11,405 | $7,500 | $2,337 |
| Non-Current Assets | |||||
| Intangibles | 2,039 | 0 | 2,039 | 2,039 | 2,039 |
| TOTAL | $2,040 | $N/A | $2,040 | $2,040 | $2,040 |
| Total Assets | $12,340 | $N/A | $13,445 | $9,539 | $4,377 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 424 | 0 | 589 | 486 | 502 |
| TOTAL | $424 | $N/A | $589 | $486 | $502 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $424 | $N/A | $589 | $486 | $502 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 272 | N/A | 257 | 175 | N/A |
| Common Shares | 23 | N/A | 22 | 15 | 5 |
| Retained earnings | -15,016 | N/A | -12,766 | -10,900 | -9,466 |
| Other shareholders' equity | 49 | 0 | 48 | 48 | 64 |
| TOTAL | $11,916 | $N/A | $12,856 | $9,054 | $3,875 |
| Total Liabilities And Equity | $12,340 | $0 | $13,445 | $9,539 | $4,377 |